Michel Dahan

Companies

• Akebia Therapeutics, Inc.Chief operating officer Mar 2, 2020 to May 14, 2024¹
• Akebia Therapeutics, Inc.SVP, Chief Business Officer Mar 18, 2016 to Apr 12, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkebia Therapeutics, Inc. AKBA672,092 shares³$474.4K at $0.71May 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• May 13, 2024Sold 34,840 shares at $1.26 of Akebia Therapeutics, Inc.³
• Feb 29, 2024Sold 8,661 shares at $1.58 of Akebia Therapeutics, Inc.⁴
• Feb 27, 2024Sold 10,744 shares at $1.52 of Akebia Therapeutics, Inc.⁵
• Jan 31, 2024Granted 149,300 shares of Akebia Therapeutics, Inc.⁶
• May 25, 2023Sold 95,478 shares at $1.22 of Akebia Therapeutics, Inc.⁷
• May 24, 2023Granted 200,000 shares of Akebia Therapeutics, Inc.⁷
• May 12, 2023Granted 200,000 shares of Akebia Therapeutics, Inc.⁸
• Mar 1, 2023Sold 1,878 shares at $0.88 of Akebia Therapeutics, Inc.⁹
• Mar 1, 2023Sold 10,476 shares at $0.88 of Akebia Therapeutics, Inc.⁹
• Mar 1, 2023Sold 8,058 shares at $0.88 of Akebia Therapeutics, Inc.⁹
• Feb 27, 2023Sold 10,090 shares at $0.81 of Akebia Therapeutics, Inc.¹⁰
• Mar 1, 2022Sold 1,232 shares at $2.17 of Akebia Therapeutics, Inc.¹¹
• Mar 1, 2022Sold 6,873 shares at $2.17 of Akebia Therapeutics, Inc.¹¹
• Mar 1, 2022Sold 6,873 shares at $2.17 of Akebia Therapeutics, Inc.¹¹
• Feb 28, 2022Granted 50,000 shares of Akebia Therapeutics, Inc.¹¹
• Feb 28, 2022Sold 6,555 shares at $2.15 of Akebia Therapeutics, Inc.¹¹